Procrastination is commonly conceptualized as a maladaptive self-regulatory failure associated with impaired performance and reduced control over task execution. However, recent research suggests that procrastination may also assume a functional form, referred to as active procrastination, characterized by intentional delay combined with preserved control and effectiveness. The present study aimed to examine the relationship between the level of procrastination and perceived control over academic tasks among psychology students, as well as to explore differences according to gender, study level, and mode of study. A quantitative cross-sectional pilot study was conducted using an online self-report survey administered to 300 psychology students aged 18–30 years from universities in southern Poland. An author-developed questionnaire with good internal consistency (Cronbach’s α = 0.84) was used to assess procrastination behaviors, perceived task control, and self-reported academic functioning. The results indicated a high prevalence of procrastination behaviors alongside high levels of declared task control, timely task completion, and satisfaction with task quality. Women reported significantly lower levels of procrastination than men, while no significant differences were observed with respect to study level or mode. The findings support the existence of a functional paradox of procrastination and provide evidence consistent with the concept of active procrastination, suggesting that perceived control may buffer the negative consequences of delaying academic tasks.
17 February 2026 in Health Problems of Civilization
Background: Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist primarily used to improve glycemic control in patients with type 2 diabetes mellitus (T2DM). It is also recommended as part of the therapeutic strategy for individuals with metabolic syndrome or obesity. This study aimed to evaluate the effects of semaglutide administration on body weight reduction, eating behaviors, energy intake, and appetite control in women with diagnosed obesity and insulin resistance. Material and methods: The study included 104 women diagnosed with obesity and insulin resistance who tolerated semaglutide therapy without adverse effects. Results: Participants using semaglutide demonstrated a mean decrease in daily energy intake of 103 kcal (p=0.034; d=-0.21) compared with baseline. A significant reduction in body weight (mean -2.85 kg) was observed, along with decreases in body fat content, Body Mass Index (BMI), and waist-to-hip ratio (WHR). Conclusions: Semaglutide use was associated with appetite suppression, reduced snacking frequency, and a subsequent decrease in body weight and body fat percentage, indicating its beneficial role in weight management among women with obesity and insulin resistance.
Introduction and objective: Bulimia nervosa (BN) is an eating disorder characterized by episodes of binge eating and the use of compensatory behaviours to control body weight. Epidemiological data suggest that BN may affect approximately 4% of the population and occurs more frequently in women....